市場調査レポート

商品コード

1401805

遺伝子治療市場：ベクタータイプ別、遺伝子タイプ別、治療別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Gene Therapy Market, By Vector Type, By Gene Type, By Therapy, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日: 2023年12月01日 | 発行: AnalystView Market Insights

| ページ情報: 英文 301 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 3,250 509,470円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは社内利用に限り可能です。PDFの印刷はできません。

PDF (5 User License)

USD 4,650 728,934円

レポートPDFを同一事業所内の5名までがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは社内利用に限り可能です。PDFの印刷は可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 5,650 885,694円

レポートPDFを企業内すべての方がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは社内利用に限り可能です。PDFの印刷は可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

レポートハイライト

遺伝子治療市場規模は2022年に83億米ドルと評価され、2023年から2030年にかけてCAGR 22.3%で拡大する見込みです。

遺伝子治療市場-市場力学

がん、希少疾患遺伝性疾患などの慢性疾患の有病率の増加が、遺伝子治療市場の成長を牽引すると世界的に予想されています。

遺伝子治療は、がんの進行を引き起こす根本的な遺伝子異常を特異的に標的とすることで、がんと闘うための有望な戦略です。世界保健機関（WHO）によると、2020年の世界のがん患者数は約1,810万人で、そのうち男性が930万人、女性が880万人です。遺伝子治療は主に、有効な従来の治療法がない希少な遺伝性疾患への対応に焦点を当てているが、米国国立生物工学情報センターの推定では、毎年49万5000人の乳児が先天性奇形で生まれ、39万人がG6PD欠損症、2万1400人がダウン症、9000人がβサラセミア、5200人が鎌状赤血球症、9760人がアミノ酸異常症です。遺伝子治療は、個人の遺伝子プロファイルに合わせた治療を行うことで、ヘルスケアに対するより個別化されたアプローチを可能にします。さらに、遺伝子治療の研究開発への投資と資金調達の増加は、市場成長の機会を生み出す可能性があります。しかし、遺伝子治療には多額の費用がかかるため、償還やアクセシビリティの面で課題があります。

遺伝子治療市場-主な洞察

当社のリサーチアナリストが共有した分析によると、世界の遺伝子治療市場は予測期間（2023-2030年）に約22.3%のCAGRで毎年成長すると予測されています。

ベクタータイプのセグメンテーションに基づくと、非ウイルスベクターが2022年に最大の市場シェアを示すと予測されました。

遺伝子タイプ別では、2022年には抗原が主要タイプになります。

治療セグメンテーションに基づくと、2022年には生体内治療が主要タイプでした。

用途別では、がん疾患が2022年の主要タイプでした。

地域別では、北米が2022年の売上高でトップ

遺伝子治療市場-セグメンテーション分析：

世界の遺伝子治療市場は、ベクタータイプ、遺伝子タイプ、治療、用途、地域に基づいてセグメント化されます。

市場はベクタータイプによって3つのカテゴリーに分けられる：ウイルスベクターと非ウイルスベクターです。市場は主に非ウイルス性ベクターによって支配されています。一般的に、非ウイルス性ベクターはウイルス性ベクターに比べて優れた安全性プロファイルを示し、それによって免疫反応や予期せぬ副作用の可能性を最小限に抑えることができます。さらに、非ウイルス性ベクターは、より大きなDNAペイロードを収容する能力を有し、より広範な遺伝物質の送達を可能にします。

市場は遺伝子の種類によって2つのカテゴリーに分けられる：抗原、サイトカイン、腫瘍抑制因子、自殺、欠損、成長因子、受容体、その他です。抗原セグメントが市場を独占しています。遺伝子治療は、疾患に関連する特定の抗原を認識し攻撃する免疫系の能力を強化する上で重要な役割を果たしています。

市場は治療法に基づき3つのカテゴリーに分けられる：生体内療法と生体外療法です。In Vivo療法が市場を独占しています。In Vivo療法は市場で重要な位置を占めています。研究者たちは、遺伝性疾患や特定のがん、その他の病状など、さまざまな疾患に対する生体内遺伝子治療を積極的に研究しています。その目的は、患者の遺伝物質を改変して治療上の利点を提供することです。

市場は、応用分野に基づいて3つのカテゴリーに分けられる：腫瘍性疾患、希少疾患、神経疾患、その他の疾患です。同市場は主にがん領域が支配的です。現在、がん疾患をターゲットとするいくつかの遺伝子治療が、さまざまな段階で臨床試験中です。特定の適応症で規制当局の承認を得ているものもあれば、まだ治験段階にあるものもあります。

遺伝子治療市場-地理的洞察

地理的には、遺伝子治療市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカに広がっています。これらの地域は、事業に関与する国によってさらに区分されます。北米地域は、高度に発達した病院インフラと細胞・遺伝子治療の需要増加により、市場の成長を支配すると予想されています。北米は、学界、産業界、ヘルスケアプロバイダー間の連携を特徴とする強固なヘルスケアエコシステムを誇っています。このような協力的な環境はイノベーションを促進し、科学的発見を臨床応用に結びつけることを促進します。American Hospital Association Information Technologyによると、2018年には98.3%の病院が電子カルテ（EHR）を導入しており、クリティカルアクセス病院（CAH）のステータスによる差はありません。さらに、58.7％と55.6％の病院が、それぞれ高度な患者エンゲージメント（PE）と臨床文書アーキテクチャ（CDA）機能を採用していました。がんや遺伝性疾患など、さまざまな疾患の治療における細胞・遺伝子治療の可能性が認識されるようになり、これらの治療に対する需要が高まっています。米国食品医薬品局（FDA）は2022年12月現在、米国（米国）において4つの遺伝子治療薬の販売を承認しています。2017年に承認されたLuxterna（voretigene neparvovec）、2019年に承認されたZolgensma（onasemnogene abeparvovec-xioi）、2020年に承認されたTecartus（brexucabtagene autoleucel）、2022年に承認されたHemgenix（etranacogene dezaparvovec）です。遺伝子治療はまだ初期段階にあるもの、以前は治療不可能と考えられていた疾患を治療し、治癒させる可能性を秘めています。欧州は、主に個別化された遺伝子ベースの治療に対する需要の高まりにより、今後数年間は遺伝子治療市場で第2位になると予測されています。

遺伝子治療市場-競合情勢：

遺伝子治療市場は、さまざまな適応症のために数多くの治療法が開発され、大きな成長を遂げています。このため、遺伝子治療開発者にとっての機会と課題を特定するための徹底的な分析が必要となる競合情勢が存在しています。製薬業界では、細胞・遺伝子治療の出現が革新的な治療をもたらし、各社は特許を重視し、先端技術の導入に戦略的な投資を行っています。こうした投資は特許ポートフォリオを強化するだけでなく、主要プレイヤーを業界の進歩の最前線に位置づける。最近の取引は、戦略的パートナーシップ、特許、雇用動向のダイナミックな変化とともに、医薬品分野における細胞・遺伝子治療の重要性を浮き彫りにしています。米国は世界の採用でリードしており、協力的な取り組み、変革的な特許、革新的な進歩の未来を形作る進化する雇用機会でリードしています。より多くの遺伝子治療が市場に参入する中、企業は患者の生活を変えるという約束を果たすため、製品と市場参入戦略を効果的に準備しなければならないです。これらの企業は、市場での成功を確保しながら、患者の利益を最大化する方法で製品を発売しなければならないです。

イントロダクション
北米
- 概要
- 北米の主要メーカー
- 米国
- カナダ
欧州
- 概要
- 欧州の主要メーカー
- ドイツ
- イタリア
- 英国
- フランス
- ロシア
- オランダ
- スウェーデン
- ポーランド
- その他
アジア太平洋（APAC）
- 概要
- アジア太平洋地域の主要メーカー
- インド
- 中国
- 日本
- 韓国
- オーストラリア
- タイ
- インドネシア
- フィリピン
- その他
ラテンアメリカ
- 概要
- ラテンアメリカの主要メーカー
- ブラジル
- メキシコ
- アルゼンチン
- コロンビア
- その他
中東とアフリカ
- 概要
- 中東およびアフリカの主要メーカー
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- トルコ
- アルジェリア
- エジプト
- その他

第12章主要ベンダー分析- 遺伝子治療産業

競合ダッシュボード
企業プロファイル
- REGENXBIO, Inc.
- Oxford BioMedica plc
- Dimension Therapeutics, Inc.
- Bristol-Myers Squibb Company
- SANOFI
- Applied Genetic Technologies Corporation
- F. Hoffmann-La Roche Ltd
- Bluebird Bio, Inc.
- Novartis AG
- Taxus Cardium Pharmaceuticals Group, Inc.（Gene Biotherapeutics）
- UniQure NV
- Shire Plc
- Cellectis SA
- Sangamo Therapeutics, Inc
- Orchard Therapeutics
- Gilead Lifesciences, Inc.
- BENITEC BIOPHARMA
- Sibiono GeneTech Co., Ltd
- Shanghai Sunway Biotech Co., Ltd.
- Gensight Biologics SA
- Transgene
- Calimmune, Inc.
- Epeius Biotechnologies Corp.
- Astellas Pharma Inc.
- American Gene Technologies
- BioMarin Pharmaceuticals, Inc.
- Others

第13章アナリストの全方位展望

図表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Gene Therapy Market: Vector Type Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Vector Type
TABLE Global Gene Therapy Market, by Vector Type 2018-2030 (USD Million)
TABLE Gene Therapy Market: Gene Type Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Gene Type
TABLE Global Gene Therapy Market, by Gene Type 2018-2030 (USD Million)
TABLE Gene Therapy Market: Therapy Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Therapy
TABLE Global Gene Therapy Market, by Therapy 2018-2030 (USD Million)
TABLE Gene Therapy Market: Application Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Gene Therapy Market, by Application 2018-2030 (USD Million)
TABLE Gene Therapy Market: Regional snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Gene Therapy Market, by Region 2018-2030 (USD Million)
TABLE North America Gene Therapy Market, by Country, 2018-2030 (USD Million)
TABLE North America Gene Therapy Market, by Vector Type, 2018-2030 (USD Million)
TABLE North America Gene Therapy Market, by Gene Type, 2018-2030 (USD Million)
TABLE North America Gene Therapy Market, by Therapy, 2018-2030 (USD Million)
TABLE North America Gene Therapy Market, by Application, 2018-2030 (USD Million)
TABLE Europe Gene Therapy Market, by Country, 2018-2030 (USD Million)
TABLE Europe Gene Therapy Market, by Vector Type, 2018-2030 (USD Million)
TABLE Europe Gene Therapy Market, by Gene Type, 2018-2030 (USD Million)
TABLE Europe Gene Therapy Market, by Therapy, 2018-2030 (USD Million)
TABLE Europe Gene Therapy Market, by Application, 2018-2030 (USD Million)
TABLE Asia Pacific Gene Therapy Market, by Country, 2018-2030 (USD Million)
TABLE Asia Pacific Gene Therapy Market, by Vector Type, 2018-2030 (USD Million)
TABLE Asia Pacific Gene Therapy Market, by Gene Type, 2018-2030 (USD Million)
TABLE Asia Pacific Gene Therapy Market, by Therapy, 2018-2030 (USD Million)
TABLE Asia Pacific Gene Therapy Market, by Application, 2018-2030 (USD Million)
TABLE Latin America Gene Therapy Market, by Country, 2018-2030 (USD Million)
TABLE Latin America Gene Therapy Market, by Vector Type, 2018-2030 (USD Million)
TABLE Latin America Gene Therapy Market, by Gene Type, 2018-2030 (USD Million)
TABLE Latin America Gene Therapy Market, by Therapy, 2018-2030 (USD Million)
TABLE Latin America Gene Therapy Market, by Application, 2018-2030 (USD Million)
TABLE Middle East and Africa Gene Therapy Market, by Country, 2018-2030 (USD Million)
TABLE Middle East and Africa Gene Therapy Market, by Vector Type, 2018-2030 (USD Million)
TABLE Middle East and Africa Gene Therapy Market, by Gene Type, 2018-2030 (USD Million)
TABLE Middle East and Africa Gene Therapy Market, by Therapy, 2018-2030 (USD Million)
TABLE Middle East and Africa Gene Therapy Market, by Application, 2018-2030 (USD Million)

List of Figures

FIGURE Gene Therapy Market Segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter's Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2022
FIGURE Vector Type segment market share analysis, 2022 & 2030
FIGURE Vector Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Gene Type segment market share analysis, 2022 & 2030
FIGURE Gene Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Therapy segment market share analysis, 2022 & 2030
FIGURE Therapy segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Application segment market share analysis, 2022 & 2030
FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Regional segment market share analysis, 2022 & 2030
FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE North America Gene Therapy Market share and leading players, 2022
FIGURE Europe Gene Therapy Market share and leading players, 2022
FIGURE Asia Pacific Gene Therapy Market share and leading players, 2022
FIGURE Latin America Gene Therapy Market share and leading players, 2022
FIGURE Middle East and Africa Gene Therapy Market share and leading players, 2022
FIGURE North America market share analysis by country, 2022
FIGURE U.S. Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Canada Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Europe Gene Therapy Market share analysis by country, 2022
FIGURE Germany Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Spain Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Italy Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE France Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE UK Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Russia Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Netherlands Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Sweden Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Poland Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of the Europe Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Asia Pacific Gene Therapy Market share analysis by country, 2022
FIGURE India Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE China Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Japan Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE South Korea Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Australia Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Thailand Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Indonesia Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Phillipines Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of APAC Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Latin America Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Latin America Gene Therapy Market share analysis by country, 2022
FIGURE Brazil Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Mexico Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Argentina Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Colombia Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of LATAM Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Middle East and Africa Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Middle East and Africa Gene Therapy Market share analysis by country, 2022
FIGURE Saudi Arabia Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE United Arab Emirates Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Israel Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Turkey Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Algeria Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Egypt Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of MEA Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)

Product Code: ANV2021

REPORT HIGHLIGHT

Gene Therapy Market size was valued at USD 8,300 Million in 2022, expanding at a CAGR of 22.3% from 2023 to 2030.

Gene therapy is a technique that modifies a person's genes to treat or cure disease. Currently, gene therapies are being utilized to address specific conditions such as Leber congenital amaurosis, an eye disorder, and spinal muscular atrophy, a muscle disorder. However, extensive research is being conducted to ensure the safety and efficacy of numerous other gene therapies. Additionally, genome editing, a promising technique currently under investigation, holds the potential to treat various disorders in the near future. It is important to note that gene therapy products are regulated by the FDA's Center for Biologics Evaluation and Research (CBER) as they are considered biological products. Another innovative technique known as genome editing, exemplified by CRISPR-Cas9, takes a different approach by utilizing molecular tools to modify the existing DNA within cells, rather than introducing new genetic material.

Gene Therapy Market- Market Dynamics

Increase in the prevalence of chronic disorders such as cancer, rare disease genetic disorders, and others globally anticipated to drive the Gene Therapy market growth.

Gene therapy presents a promising strategy for combating cancer by specifically targeting the underlying genetic abnormalities responsible for its progression. According to the World Health Organization, there were approximately 18.1 million cancer cases worldwide in 2020, with 9.3 million affecting men and 8.8 million affecting women. While gene therapies primarily focus on addressing rare genetic disorders that lack effective traditional treatment options, the National Center for Biotechnology Information estimates that each year, 495,000 infants are born with congenital malformations, 390,000 with G6PD deficiency, 21,400 with Down syndrome, 9,000 with beta-thalassemia, 5,200 with sickle cell disease, and 9,760 with amino acid disorders. By tailoring treatment to an individual's specific genetic profile, gene therapy enables a more personalized approach to healthcare. Moreover, increased investment and funding in gene therapy research and development can create opportunities for market growth. However, the substantial cost associated with gene therapies presents challenges in terms of reimbursement and accessibility.

Gene Therapy Market- Key Insights

As per the analysis shared by our research analyst, the global Gene Therapy market is estimated to grow annually at a CAGR of around 22.3% over the forecast period (2023-2030)

Based on Vector Type segmentation, Non-viral vectors was predicted to show maximum market share in the year 2022

Based on Gene Type segmentation, Antigen was the leading type in 2022

Based on Therapy segmentation, In Vivo Therapy was the leading type in 2022

Based on Application segmentation, Oncological Disorders was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Gene Therapy Market- Segmentation Analysis:

The Global Gene Therapy Market is segmented based on Vector Type, Gene Type, Therapy, Application, and Region.

The market is divided into three categories based on Vector Type: Viral Vector and Non-Viral Vector. The market is primarily dominated by Non-Viral Vectors. Generally, Non-viral vectors exhibit a superior safety profile compared to viral vectors, thereby minimizing the chances of immune responses or unintended side effects. Moreover, Non-viral vectors possess the capability to accommodate larger DNA payloads, enabling the delivery of more extensive genetic material.

The market is divided into two categories based on Gene Type: Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth factors, Receptors and Others. The antigen segment dominates the market. Gene therapy plays a significant role in enhancing the immune system's ability to recognize and attack specific antigens associated with diseases.

The market is divided into three categories based on Therapy: In Vivo Therapy and Ex Vivo Therapy. In Vivo Therapy dominates the market. In Vivo Therapy holds a significant position in the market. Researchers are actively investigating in vivo gene therapy for various diseases, such as genetic disorders, specific forms of cancer, and other medical conditions. The aim is to modify the patient's genetic material to offer therapeutic advantages.

The market is divided into three categories based on Application: Oncological Disorders, Rare Diseases, Neurological Disorders and Other Diseases. The market is primarily dominated by the Oncological Disorders segment. Several gene therapies targeting oncological disorders are currently undergoing clinical trials at different stages. Certain therapies have obtained regulatory approvals for specific indications, whereas others are still in the investigational phases.

Gene Therapy Market- Geographical Insights

Geographically, this market is widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in the business. The North American region is expected to dominate the market's growth due to its highly advanced hospital infrastructure and the increasing demand for cell and gene therapy. North America boasts a robust healthcare ecosystem characterized by collaborations between academia, industry, and healthcare providers. This collaborative environment fosters innovation and expedites the translation of scientific discoveries into clinical applications. According to the American Hospital Association Information Technology, in 2018, 98.3% of hospitals had adopted Electronic Health Records (EHRs), with no differences based on Critical Access Hospital (CAH) status. Additionally, 58.7% and 55.6% of hospitals had adopted advanced Patient Engagement (PE) and Clinical Document Architecture (CDA) functions, respectively. The growing recognition of the potential of cell and gene therapies in treating various diseases, including cancer and genetic disorders, has led to an increasing demand for these therapies. The United States Food and Drug Administration (FDA) has approved four gene therapies for sale in the United States (U.S.) as of December 2022: Luxterna (voretigene neparvovec) approved in 2017, Zolgensma (onasemnogene abeparvovec-xioi) approved in 2019, Tecartus (brexucabtagene autoleucel) approved in 2020, and Hemgenix (etranacogene dezaparvovec) approved in 2022. Although still in its early stages, gene therapy holds the potential to treat and potentially cure diseases that were previously considered untreatable. Europe is projected to be the second-largest gene therapy market in the upcoming years, primarily due to the growing demand for personalized gene-based treatments.

Gene Therapy Market- Competitive Landscape:

The gene therapy market is experiencing significant growth with numerous therapies being developed for various indications. This presents a competitive landscape that requires thorough analysis to identify opportunities and challenges for gene therapy developers. In the pharmaceutical industry, the emergence of cell and gene therapy has brought about innovative treatments, with companies focusing on patents and investing strategically to introduce advanced technologies. These investments not only enhance patent portfolios but also position key players at the forefront of industry advancements. Recent deals highlight the importance of cell and gene therapy in the pharmaceutical sector, with dynamic shifts in strategic partnerships, patents, and job trends. The United States leads in global adoption, with collaborative efforts, transformative patents, and evolving job opportunities shaping the future of innovative advancements. As more gene therapies enter the market, companies must effectively prepare their products and go-to-market strategies to fulfill their promise of transforming patient lives. These companies must launch their products in a way that maximizes patient benefits while ensuring success in the market.

Recent Developments:

In Dec 22, 2021, Novartis announced that it entered into a definitive agreement to acquire all of the outstanding share capital of the UK-based ocular gene therapy company Gyroscope Therapeutics. Geographic atrophy is an advanced form of dry age-related macular degeneration leading to advanced and irreversible idea loss1.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENE THERAPY MARKET KEY PLAYERS

REGENXBIO, Inc.
Oxford BioMedica plc
Dimension Therapeutics, Inc.
Bristol-Myers Squibb Company
SANOFI
Applied Genetic Technologies Corporation
F. Hoffmann-La Roche Ltd
Bluebird Bio, Inc.
Novartis AG
Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
UniQure N.V.
Shire Plc
Cellectis S.A.
Sangamo Therapeutics, Inc
Orchard Therapeutics
Gilead Lifesciences, Inc.
BENITEC BIOPHARMA
Sibiono GeneTech Co., Ltd
Shanghai Sunway Biotech Co., Ltd.
Gensight Biologics S.A.
Transgene
Calimmune, Inc.
Epeius Biotechnologies Corp.
Astellas Pharma Inc.
American Gene Technologies
BioMarin Pharmaceuticals, Inc.
Others

GLOBAL GENE THERAPY MARKET, BY VECTOR TYPE

Viral Vector
Non-Viral Vector

GLOBAL GENE THERAPY MARKET, BY GENE TYPE

Antigen
Cytokine
Tumor Suppressor
Suicide
Deficiency
Growth factors
Receptors
Others

GLOBAL GENE THERAPY MARKET, BY THERAPY

In Vivo Therapy
Ex Vivo Therapy

GLOBAL GENE THERAPY MARKET, BY APPLICATION

Oncological Disorders
Rare Diseases
Neurological Disorders
Other Diseases

GLOBAL GENE THERAPY MARKET, BY REGION

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Gene Therapy Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Gene Therapy Market Snippet by Vector Type
- 2.1.2. Gene Therapy Market Snippet by Gene Type
- 2.1.3. Gene Therapy Market Snippet by Therapy
- 2.1.4. Gene Therapy Market Snippet by Application
- 2.1.5. Gene Therapy Market Snippet by Country
- 2.1.6. Gene Therapy Market Snippet by Region
2.2. Competitive Insights

3. Gene Therapy Key Market Trends

3.1. Gene Therapy Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Gene Therapy Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Gene Therapy Market Opportunities
3.4. Gene Therapy Market Future Trends

4. Gene Therapy Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Gene Therapy Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Gene Therapy Market Landscape

6.1. Gene Therapy Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Gene Therapy Market - By Vector Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Vector Type, 2022 & 2030 (%)
- 7.1.2. Viral Vector
- 7.1.3. Non-Viral Vector

8. Gene Therapy Market - By Gene Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Gene Type, 2022 & 2030 (%)
- 8.1.2. Antigen
- 8.1.3. Cytokine
- 8.1.4. Tumor Suppressor
- 8.1.5. Suicide
- 8.1.6. Deficiency
- 8.1.7. Growth factors
- 8.1.8. Receptors
- 8.1.9. Others

9. Gene Therapy Market - By Therapy

9.1. Overview
- 9.1.1. Segment Share Analysis, By Therapy, 2022 & 2030 (%)
- 9.1.2. In Vivo Therapy
- 9.1.3. Ex Vivo Therapy

10. Gene Therapy Market - By Application

10.1. Overview
- 10.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 10.1.2. Oncological Disorders
- 10.1.3. Rare Diseases
- 10.1.4. Neurological Disorders
- 10.1.5. Other Diseases

11. Gene Therapy Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Gene Therapy Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Gene Therapy Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.9. Italy
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.3.9.3. Italy Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.3.9.4. Italy Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.3.9.5. Italy Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.3.9.6. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.10. United Kingdom
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.3.10.3. United Kingdom Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.3.10.4. United Kingdom Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.3.10.5. United Kingdom Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.3.10.6. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.11. France
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.3.11.3. France Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.3.11.4. France Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.3.11.5. France Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.3.11.6. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.12. Russia
  - 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.3.12.2. Russia Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.3.12.3. Russia Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.3.12.4. Russia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.3.12.5. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.13. Netherlands
  - 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.3.13.2. Netherlands Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.3.13.3. Netherlands Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.3.13.4. Netherlands Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.3.13.5. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.3.14.2. Sweden Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.15. Poland
  - 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.3.15.2. Poland Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.3.15.3. Poland Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.3.15.4. Poland Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.3.15.5. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.16. Rest of Europe
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.3.16.3. Rest of the Europe Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.3.16.4. Rest of the Europe Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.3.16.5. Rest of the Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.3.16.6. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Gene Therapy Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.8. India
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.4.8.3. India Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.4.8.4. India Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.4.8.5. India Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.4.8.6. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.9. China
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.4.9.3. China Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.4.9.4. China Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.4.9.5. China Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.4.9.6. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.13. Thailand
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.4.13.3. Thailand Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.4.13.4. Thailand Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.4.13.5. Thailand Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.4.13.6. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.14. Indonesia
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.4.14.3. Indonesia Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.4.14.4. Indonesia Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.4.14.5. Indonesia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.4.14.6. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Gene Therapy Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Gene Therapy Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Gene Therapy Industry

12.1. Competitive Dashboard
12.2. Company Profiles
- 12.2.1. REGENXBIO, Inc.
- 12.2.2. Oxford BioMedica plc
- 12.2.3. Dimension Therapeutics, Inc.
- 12.2.4. Bristol-Myers Squibb Company
- 12.2.5. SANOFI
- 12.2.6. Applied Genetic Technologies Corporation
- 12.2.7. F. Hoffmann-La Roche Ltd
- 12.2.8. Bluebird Bio, Inc.
- 12.2.9. Novartis AG
- 12.2.10. Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
- 12.2.11. UniQure N.V.
- 12.2.12. Shire Plc
- 12.2.13. Cellectis S.A.
- 12.2.14. Sangamo Therapeutics, Inc
- 12.2.15. Orchard Therapeutics
- 12.2.16. Gilead Lifesciences, Inc.
- 12.2.17. BENITEC BIOPHARMA
- 12.2.18. Sibiono GeneTech Co., Ltd
- 12.2.19. Shanghai Sunway Biotech Co., Ltd.
- 12.2.20. Gensight Biologics S.A.
- 12.2.21. Transgene
- 12.2.22. Calimmune, Inc.
- 12.2.23. Epeius Biotechnologies Corp.
- 12.2.24. Astellas Pharma Inc.
- 12.2.25. American Gene Technologies
- 12.2.26. BioMarin Pharmaceuticals, Inc.
- 12.2.27. Others

13. 360 Degree Analyst View

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us

遺伝子治療市場：ベクタータイプ別、遺伝子タイプ別、治療別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Gene Therapy Market, By Vector Type, By Gene Type, By Therapy, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

レポートハイライト

遺伝子治療市場-セグメンテーション分析：

遺伝子治療市場-競合情勢：

目次

第1章 遺伝子治療市場概要

第2章 エグゼクティブサマリー

第3章 遺伝子治療の主要な市場動向

第4章 遺伝子治療産業の調査

第5章 遺伝子治療市場：COVID-19の影響分析

第6章 遺伝子治療市場情勢

第7章 遺伝子治療市場- ベクタータイプ別

第8章 遺伝子治療市場- 遺伝子タイプ別

第9章 遺伝子治療市場- 治療別

第10章 遺伝子治療市場- 用途別

第11章 遺伝子治療市場-地域別

第12章 主要ベンダー分析- 遺伝子治療産業

第13章 アナリストの全方位展望